Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT01046006 · COMPLETED
Trial details
- NCT number
- NCT01046006
- Sponsor
- Meletios A. Dimopoulos
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2010-11-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.